Stacey Stein, MD, and Neal Fischbach, MD, have been named Assistant Medical Directors for Yale Cancer Center’s Clinical Trials Office. As Assistant Medical Director of the Clinical Trials Office, Stein will be responsible for the quality and medical direction of the clinical trials unit at Smilow Cancer Hospital. Fischbach was named Assistant Medical Director of the Clinical Trials Office for the Smilow Cancer Hospital Care Center Network and will continue to grow the clinical trial prospects throughout the 15 care centers in Connecticut and Westerly, RI.
“As clinical trial opportunities expand across the Smilow Cancer Hospital Network and more clinical trials open, we recognize the need for an expanded leadership team in our Clinical Trials Office to support our clinical research staff and mission,” said Roy S. Herbst, MD, PhD, Chief of Medical Oncology, Associate Cancer Center Director for Translational Research, and Acting Associate Cancer Center Director for Clinical Sciences at Yale Cancer Center and Smilow Cancer Hospital. “We are thrilled Dr. Stein and Dr. Fischbach are expanding their responsibilities to further benefit our hospital and our patients.”
Stein joined Yale Cancer Center in 2010 and has led numerous clinical trials over the last decade. She has served on the Protocol Review Committee at Yale Cancer Center since 2013 and has been vice-chair since 2019. Her passion for clinical research and expanding the prospects for patients will translate to continued improvements in clinical trial opportunities through the Yale Cancer Center Clinical Trials Office.
Fischbach has been serving as Assistant Director for Clinical Research for the Smilow Cancer Hospital Care Center Network since 2019. Fischbach will work to support growth and collaboration to achieve clinical research goals for each of the Yale Cancer Center providers in the Smilow Cancer Hospital Care Centers.